*¼¼Æ÷±âÁú¿¬±¸¼Ò ÃÊû¼¼¹Ì³ª
ÆäÀÌÁö Á¤º¸
ÀÛ¼ºÀÚ °ü¸®ÀÚ ÀÛ¼ºÀÏ13-10-15 11:37 Á¶È¸4,464ȸ ´ñ±Û0°Ç÷ºÎÆÄÀÏ
-
°¡°è°ï¶õ ÀåÇÐ±Ý ½Åû¼.hwp
(0byte)
86ȸ ´Ù¿î·Îµå
DATE : 2015-02-27 13:59:02
º»¹®
*¼¼Æ÷±âÁú¿¬±¸¼Ò ÃÊû¼¼¹Ì³ª
Àå¼Ò: Á¦2±³¼öȸÀǽÇ(º»°ü 2Ãþ ¼Æí)
¹®ÀÇ: ·ù¸¶Æ¼½º³»°ú °¿µ¸ð(5495)
1. Updates on the developmetal technology of anti-TNF blocker - Omid Vafa, PhD
2. Clinical trials of Golimumab and the pipeline of immunomodulatory agents in Johnson & Johnson - Raphael DeHoratius, MD, PhD
ÀϽÃ: 2013³â 10¿ù 21ÀÏ (¿ù) 17:00 Àå¼Ò: Á¦2±³¼öȸÀǽÇ(º»°ü 2Ãþ ¼Æí)
¹®ÀÇ: ·ù¸¶Æ¼½º³»°ú °¿µ¸ð(5495)